Medicilon Subsidiary Medicilon (Hangzhou) Inc. Grandly Opened!

저자：medicilon   업로드：2022-09-14  조회수：

On September 7, 2022, the opening ceremony of Medicilon (Hangzhou) Inc., a subsidiary of Shanghai Medicilon Inc., was held in Hangzhou.

Medicilon (Hangzhou) will build as a CRO research center. The nearly 8,000-square-meter R&D laboratory will focus on the biopharmaceuticals and AI pharmaceuticals, such as chemical drug synthesis research, compound synthesis, compound activity screening and other services. This could accelerate the industrialization of research results.

이전：Collaboration to empower gene therapy, OBiO Technology and Medicilon reach a strategic collaboration

다음에：Medicilon was selected as 2022 Shanghai Top 100 Emerging Industry Enterprises